|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"wu cheng chung"
Showing items 1-25 of 44 (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2021-11-25T03:13:19Z |
Metabolic risk factors are associated with non-hepatitis B non-hepatitis C hepatocellular carcinoma in Taiwan, an endemic area of chronic hepatitis B
|
Huang, Shiu-Feng; Chang, Il-Chi; Hong, Chih-Chen; Yen, Tseng-Chang; Chen, Chao-Long; Wu, Cheng-Chung; Tsai, Cheng-Chung; MING-CHIH HO; Lee, Wei-Chen; Yu, Hsien-Chung; Shen, Ying-Ying; Eng, Hock-Liew; Wang, John; Tseng, Hui-Hwa; Jeng, Yung-Ming; Yeh, Chau-Ting; Chen, Chi-Ling; Chen, Pei-Jer; Liaw, Yun-Fan |
| 臺大學術典藏 |
2018-09-10T15:32:52Z |
The Hepatitis Viral Status in Patients with Hepatocellular Carcinoma: A Study of 3843 Patients from Taiwan Liver Cancer Network
|
Chang, Il-Chi;Huang, Shiu-Feng;Chen, Pei-Jer;Chen, Chi-Ling;Chen, Chao-Long;Wu, Cheng-Chung;Tsai, Cheng-Chung;Lee, Po-Huang;Chen, Miin-Fu;Lee, Chuan-Mo;Yu, Hsien-Chung;Lo, Gin-Ho;Yeh, Chau-Ting;Hong, Chih-Chen;Eng, Hock-Liew;Wang, John;Tseng, Hui-Hwa;Hsiao, Cheng-Hsiang;Wu, Hong-Dar Isaac;Yen, Tseng-Chang;Liaw, Yun-Fan; Chang, I.-C. and Huang, S.-F. and Chen, P.-J. and Chen, C.-L. and Chen, C.-L. and Wu, C.-C. and Tsai, C.-C. and Lee, P.-H. and Chen, M.-F. and Lee, C.-M. and Yu, H.-C. and Lo, G.-H. and Yeh, C.-T. and Hong, C.-C. and Eng, H.-L. and Wang, J. and Tseng, H.-H. and Hsiao, C.-H. and Wu, H.-D.I. and Yen, T.-C. and Liaw, Y.-F.; 蕭正祥;陳培哲;李伯皇;陳祈玲; Chang, Il-Chi; PEI-JER CHEN; Huang, Shiu-Feng; Chen, Pei-Jer; Chen, Chi-Ling; Chen, Chao-Long; Wu, Cheng-Chung; Tsai, Cheng-Chung; Lee, Po-Huang; Chen, Miin-Fu; Lee, Chuan-Mo; Yu, Hsien-Chung; Lo, Gin-Ho; Yeh, Chau-Ting; Hong, Chih-Chen; Eng, Hock-Liew; Wang, John; Tseng, Hui-Hwa; Hsiao, Cheng-Hsiang; Wu, Hong-Dar Isaac; Yen, Tseng-Chang; Liaw, Yun-Fan |
| 臺大學術典藏 |
2018-09-10T14:57:15Z |
Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
|
Liu, C.-J. and Chang, J. and Lee, P.-H. and Lin, D.-Y. and Wu, C.-C. and Jeng, L.-B. and Lin, Y.-J. and Mok, K.-T. and Lee, W.-C. and Yeh, H.-Z. and Ho, M.-C. and Yang, S.-S. and Yang, M.-D. and Yu, M.-C. and Hu, R.-H. and Peng, C.-Y. and Lai, K.-L. and Chang, S.S.-C. and Chen, P.-J.; Liu, Chun-Jen;Chang, Juliana;Lee, Po-Huang;Lin, Deng-Yn;Wu, Cheng-Chung;Jeng, Long-Bin;Lin, Yih-Jyh;Mok, King-Tong;Lee, Wei-Chen;Yeh, Hong-Zen;Ho, Ming-Chih;Yang, Sheng-Shun;Yang, Mei-Due;Yu, Ming-Chin;Hu, Rey-Heng;Peng, Cheng-Yuan;Lai, Kuan-Lang;Chang, Stanley Shi-Chung;Chen, Pei-Jer; 胡瑞恒;劉俊人;陳培哲;李伯皇;何明志; MING-CHIH HO; Liu, Chun-Jen; Chang, Juliana; CHUN-JEN LIU; Lee, Po-Huang; PEI-JER CHEN; REY-HENG HU; Lin, Deng-Yn; Wu, Cheng-Chung; Jeng, Long-Bin; Lin, Yih-Jyh; Mok, King-Tong; Lee, Wei-Chen; Yeh, Hong-Zen; Ho, Ming-Chih; Yang, Sheng-Shun; Yang, Mei-Due; Yu, Ming-Chin; Hu, Rey-Heng; Peng, Cheng-Yuan; Lai, Kuan-Lang; Chang, Stanley Shi-Chung; Chen, Pei-Jer |
| 臺大學術典藏 |
2018-09-10T09:40:38Z |
Osteopontin promoter polymorphisms are associated with susceptibility to gastric cancer
|
Lee, Teng-Yu;Lin, Jaw-Town;Wu, Cheng-Chung;Yu, Cheng-Chan;Wu, Ming-Shiang;Lee, Tso-Ching;Chen, Hsiao-Ping;Wu, Chun-Ying; Lee, T.-Y. and Lin, J.-T. and Wu, C.-C. and Yu, C.-C. and Wu, M.-S. and Lee, T.-C. and Chen, H.-P. and Wu, C.-Y.; 吳明賢; MING-SHIANG WU; Lee, Teng-Yu; Lin, Jaw-Town; Wu, Cheng-Chung; Yu, Cheng-Chan; Wu, Ming-Shiang; Lee, Tso-Ching; Chen, Hsiao-Ping; Wu, Chun-Ying |
| 臺大學術典藏 |
2018-09-10T09:21:36Z |
Long-term results of a randomized, observation-controlled, phase III Trial of Adjuvant Interferon alfa-2b in hepatocellular carcinoma after curative resection
|
Chen, Miin-Fu; Li, Lung-An; Lee, Po-Huang; Lee, Po-Huang; Jeng, Long-Bin; Lin, Deng-Yn; Wu, Cheng-Chung; Mok, King-Tong; Chen, Chao-Long; Lee, Wei-Chen; Chau, Gar-Yang; Chen, Yaw-Sen; Lui, Wing-Yui; Hsiao, Chin-Fu; Hsiao, Chin-Fu; Whang-Peng, Jacqueline; Chen, Pei-Jer; Chen, Pei-Jer; Chen, L.-T. and Chen, M.-F. and Li, L.-A. and Lee, P.-H. and Jeng, L.-B. and Lin, D.-Y. and Wu, C.-C. and Mok, K.-T. and Chen, C.-L. and Lee, W.-C. and Chau, G.-Y. and Chen, Y.-S. and Lui, W.-Y. and Hsiao, C.-F. and Whang-Peng, J. and Chen, P.-J.; Chen, Li-Tzong;Chen, Miin-Fu;Li, Lung-An;Lee, Po-Huang;Jeng, Long-Bin;Lin, Deng-Yn;Wu, Cheng-Chung;Mok, King-Tong;Chen, Chao-Long;Lee, Wei-Chen;Chau, Gar-Yang;Chen, Yaw-Sen;Lui, Wing-Yui;Hsiao, Chin-Fu;Whang-Peng, Jacqueline;Chen, Pei-Jer; 陳培哲 ;李伯皇; Chen, Li-Tzong; Chen, Li-Tzong; PEI-JER CHEN |
| 臺大學術典藏 |
2018-09-10T09:14:11Z |
The binding affinity and molecular basis of the structure-binding relationship between urinary tamm-horsfall glycoprotein and tumor necrosis factor-α
|
Chang, Juliana; Li, Ko-Jen; Lee, Po-Huang; Siao, Sue-Cien; Siao, Sue-Cien; Chen, Yu-Hsuan; Chen, Yu-Hsuan; Lin, Deng-Yn; Wu, Tsai-Hung; Wu, Cheng-Chung; Wu, Tsai-Hung; Jeng, Long-Bin; Tsai, Chang-Youh; Tsai, Chang-Youh; Lin, Yih-Jyh; Yu, Chia-Li; Yu, Chia-Li; Mok, King-Tong; Lee, Wei-Chen; Yeh, Hong-Zen; Ho, Ming-Chih; Yang, Sheng-Shun; Yang, Mei-Due; Yu, Ming-Chin; Hu, Rey-Heng; Peng, Cheng-Yuan; Lai, Kuan-Lang; Chang, Stanley Shi-Chung; Chen, Pei-Jer; 胡瑞恒; 劉俊人; 陳培哲; 李伯皇; 何明志; Wu, C.-H. and Li, K.-J. and Siao, S.-C. and Chen, Y.-H. and Wu, T.-H. and Tsai, C.-Y. and Yu, C.-L.; Wu, Cheng-Han;Li, Ko-Jen;Siao, Sue-Cien;Chen, Yu-Hsuan;Wu, Tsai-Hung;Tsai, Chang-Youh;Yu, Chia-Li; Wu, Cheng-Han;Li, Ko-Jen;Siao, Sue-Cien;Chen, Yu-Hsuan;Wu, Tsai-Hung;Tsai, Chang-Youh;Yu, Chia-Li; 余家利;吳政翰; Liu, Chun-Jen; Wu, Cheng-Han; CHENG-HAN WU; Wu, Cheng-Han; Li, Ko-Jen |
| 臺大學術典藏 |
2018-09-10T07:26:51Z |
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage
|
Liu, C.-J. and Lee, P.-H. and Lin, D.-Y. and Wu, C.-C. and Jeng, L.-B. and Lin, P.-W. and Mok, K.-T. and Lee, W.-C. and Yeh, H.-Z. and Ho, M.-C. and Yang, S.-S. and Lee, C.-C. and Yu, M.-C. and Hu, R.-H. and Peng, C.-Y. and Lai, K.-L. and Chang, S.S.-C. and Chen, P.-J.; 劉俊人;李伯皇;胡瑞恆;吳誠中;鄭隆賓;林炳文;莫景棠;葉宏仁;何明志;楊勝舜;陳培哲; LIU, CHUN-JEN;LEE, PO-HUANG;HU, REY-HENG;WU, CHENG-CHUNG;JENG, LONG-BIN;LIN, PIN-WEN;MOK, KING-TONG;YEH, HONG-ZEN;HO, MING-CHIH;YANG, SHENG-SHUN;CHEN, PEI-JER; MING-CHIH HO; PO-HUANG LEE; CHUN-JEN LIU; PEI-JER CHEN; REY-HENG HU; LIU, CHUN-JEN; LEE, PO-HUANG; HU, REY-HENG; WU, CHENG-CHUNG; JENG, LONG-BIN; LIN, PIN-WEN; MOK, KING-TONG; YEH, HONG-ZEN; HO, MING-CHIH; YANG, SHENG-SHUN; CHEN, PEI-JER |
| 國立臺灣大學 |
2016 |
The Hepatitis Viral Status in Patients With Hepatocellular Carcinoma: a Study of 3843 Patients From Taiwan Liver Cancer Network
|
Chang, Il-Chi; Huang, Shiu-Feng; Chen, Pei-Jer; Chen, Chi-Ling; Chen, Chao-Long; Wu, Cheng-Chung; Tsai, Cheng-Chung; Lee, Po-Huang; Chen, Miin-Fu; Lee, Chuan-Mo; Yu, Hsien-Chung; Lo, Gin-Ho; Yeh, Chau-Ting; Hong, Chih-Chen; Eng, Hock-Liew; Wang, John; Tseng, Hui-Hwa; Hsiao, Cheng-Hsiang; Wu, Hong-Dar Isaac; Yen, Tseng-Chang; Liaw, Yun-Fan; 蕭正祥; 陳培哲; 李伯皇; 陳祈玲 |
| 大葉大學 |
2015-11 |
Methylation-silencing RCC1 expression is associated with tumorigenesis and depth of invasion in gastric cancer.
|
Lin, Yi-Ling;Ling, Chen Hsiao;Cheng, Shao-Bin;Yeh, Dah-Cherng;Huang, Chu-Chun;P’eng, Fang-Ku;Tsai, Tung-Chou;Wu, Cheng-Chung;Chen, Chuan-Mu |
| 國立臺灣大學 |
2015 |
Akt suppresses DLK for maintaining self-renewal of mouse embryonic stem cells
|
Wu, Cheng-Chung; Wu, Hong-Jin; Wang, Chia-Hui; Lin, Chia-Hua; Hsu, Shu-Ching; Chen, Yi-Rong; Hsiao, Michael; Schuyler, Scott C.; Lu, Frank Leigh; Ma, Nianhan; Lu, Jean; 呂立 |
| 國立臺灣大學 |
2015 |
Randomized, phase III trial of adjuvant adeforvir vs. therapeutic lamivudine in post-operative BCLC stage 0 or A HBV-related HCC: The Taiwan Cooperative Oncology Group T1206 study
|
Chen, Li-Tzong; Jeng, Long-Bin; Hsiao, Chin-Fu; Wu, Cheng-Chung; Lee, Wei-Chen; Wang, Tsang-En; Lee, Po-Huang; Chen, Chao-Long; Chen, I-Su; Lee, King-Teh; Hsieh, Chung-Bao; Hwang, Wei-Shou; Yang, Mei-Due; Yang, Yang-Sen; Lin, Deng-Yn; Chen, Miin-Fu; Chen, Pei-Jer; 陳培哲; 李伯皇 |
| 國立成功大學 |
2014-08-28 |
Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
|
Liu, Chun-Jen; Chang, Juliana; Lee, Po-Huang; Lin, Deng-Yn; Wu, Cheng-Chung; Jeng, Long-Bin; Lin, Yih-Jyh; Mok, King-Tong; Lee, Wei-Chen; Yeh, Hong-Zen; Ho, Ming-Chih; Yang, Sheng-Shun; Yang, Mei-Due; Yu, Ming-Chin; Hu, Rey-Heng; Peng, Cheng-Yuan; Lai, Kuan-Lang; Chang, Stanley Shi-Chung; Chen, Pei-Jer |
| 國立成功大學 |
2014-04 |
A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer
|
Chao, Yee; Hsieh, Jan-Sing; Yeh, Hsien-Tang; Su, Yu-Chieh; Wu, Cheng-Chung; Chen, Jen-Shi; Tai, Cheng-Jeng; Bai, Li-Yuan; Yeh, Kun-Huei; Su, Wu-Chou; Li, Chung-Pin |
| 臺北醫學大學 |
2014 |
A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer
|
Chao, Yee;Hsieh, Jan-Sing;Yeh, Hsien-Tang;Su, Yu-Chieh;Wu, Cheng-Chung;Chen, Jen-Shi;Tai, Cheng-Jeng;Bai, Li-Yuan;Yeh, Kun-Huei;Su, Wu-Chou;Li, Chung-Pin |
| 臺北醫學大學 |
2014 |
Is Liver Resection for Hepatocellular Carcinoma in Cirrhotic Patients with High Preoperative Serum Alanine Aminotransferase Level Unadvisable?
|
Lai, Chia-Yu;Wu, Cheng-Chung;Wang, John;Yu, Cheng-Chan;Cheng, Shao-Bin;Yeh, Dar-Cherng;Peng, Fang-Ku |
| 國立臺灣大學 |
2014 |
Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
|
Liu, Chun-Jen; Chang, Juliana; Lee, Po-Huang; Lin, Deng-Yn; Wu, Cheng-Chung; Jeng, Long-Bin; Lin, Yih-Jyh; Mok, King-Tong; Lee, Wei-Chen; Yeh, Hong-Zen; Ho, Ming-Chih; Yang, Sheng-Shun; Yang, Mei-Due; Yu, Ming-Chin; Hu, Rey-Heng; Peng, Cheng-Yuan; Lai, Kuan-Lang; Chang, Stanley Shi-Chung; Chen, Pei-Jer; 胡瑞恒; 劉俊人; 陳培哲; 李伯皇; 何明志 |
| 國立成功大學 |
2013-08-30 |
應用可靠度方法發展國道鋪面服務壽命預測模型 － 以不完整之國際糙度指標歷史資料為例
|
吳政忠; Wu, Cheng-Chung |
| 國立臺灣大學 |
2013 |
Osteopontin Promoter Polymorphisms are Associated With Susceptibility to Gastric Cancer
|
Lee, Teng-Yu; Lin, Jaw-Town; Wu, Cheng-Chung; Yu, Cheng-Chan; Wu, Ming-Shiang; Lee, Tso-Ching; Chen, Hsiao-Ping; Wu, Chun-Ying; 吳明賢 |
| 東海大學 |
2012-04 |
Apoptosis induced by hepatitis B virus X protein (HBx) in a CCL13-HBx (Chang-HBx) stable cell line
|
黃光裕; Kuo, Chan-Yen; Tsai, Ju-I; Chou, Tzu-Yu; Hung, Man-Jung; Wu, Cheng-Chung; Hsu, Shih-Lan; Hwang, Guang-Yuh |
| 國立成功大學 |
2012-01 |
Long-Term Results of a Randomized, Observation-Controlled, Phase III Trial of Adjuvant Interferon Alfa-2b in Hepatocellular Carcinoma After Curative Resection
|
Chen, Li-Tzong; Chen, Miin-Fu; Li, Lung-An; Lee, Po-Huang; Jeng, Long-Bin; Lin, Deng-Yn; Wu, Cheng-Chung; Mok, King-Tong; Chen, Chao-Long; Lee, Wei-Chen; Chau, Gar-Yang; Chen, Yaw-Sen; Lui, Wing-Yui; Hsiao, Chin-Fu; Whang-Peng, Jacqueline; Chen, Pei-Jer |
| 國立臺灣大學 |
2012 |
Long-Term Results of a Randomized, Observation-Controlled, Phase III Trial of Adjuvant Interferon Alfa-2b in Hepatocellular Carcinoma After Curative Resection
|
Chen, Li-Tzong; Chen, Miin-Fu; Li, Lung-An; Lee, Po-Huang; Jeng, Long-Bin; Lin, Deng-Yn; Wu, Cheng-Chung; Mok, King-Tong; Chen, Chao-Long; Lee, Wei-Chen; Chau, Gar-Yang; Chen, Yaw-Sen; Lui, Wing-Yui; Hsiao, Chin-Fu; Whang-Peng, Jacqueline; Chen, Pei-Jer; 陳培哲; 李伯皇 |
| 國立臺灣大學 |
2012 |
A shRNA Functional Screen Reveals Nme6 and Nme7 Are Crucial for Embryonic Stem Cell Renewal
|
Wang, Chia-Hui; Ma, Nianhan; Lin, Yu-Tsen; Wu, Cheng-Chung; Hsiao, Michael; Lu, Frank Leigh; Yu, Ching-Chia; Chen, Shao-Yin; Lu, Jean; 呂立 |
| 國立成功大學 |
2011-02-20 |
High resolution melting analysis for the detection of SLC25A13 gene mutations in Taiwan
|
Lin, Jing-Ting; Hsiao, Kwang-Jen; Chen, Chiung-Yu; Wu, Cheng-Chung; Lin, Shio-Jean; Chou, Yen-Yin; Shiesh, Shu-Chu |
| 國立高雄第一科技大學 |
2010-10-25 |
房屋貸款違約與提前清償風險因素之研究
|
吳政仲; Wu Cheng-Chung |
| 國立高雄第一科技大學 |
2009.08 |
Hedging with derivatives by Taiwanese listed non-financial companies
|
Hsu, Shuofen;Ko, Po-Sheng;Wu, Cheng-Chung;Cheng, Shuen-Ren;Chen, Yung-Sheng |
Showing items 1-25 of 44 (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page
|
